165 related articles for article (PubMed ID: 9288724)
1. Acquired CD40-ligand deficiency in chronic lymphocytic leukemia.
Cantwell M; Hua T; Pappas J; Kipps TJ
Nat Med; 1997 Sep; 3(9):984-9. PubMed ID: 9288724
[TBL] [Abstract][Full Text] [Related]
2. Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells.
Furman RR; Asgary Z; Mascarenhas JO; Liou HC; Schattner EJ
J Immunol; 2000 Feb; 164(4):2200-6. PubMed ID: 10657675
[TBL] [Abstract][Full Text] [Related]
3. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
4. CD40 ligand in CLL pathogenesis and therapy.
Schattner EJ
Leuk Lymphoma; 2000 May; 37(5-6):461-72. PubMed ID: 11042507
[TBL] [Abstract][Full Text] [Related]
5. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells.
Skov S; Bonyhadi M; Odum N; Ledbetter JA
J Immunol; 2000 Apr; 164(7):3500-5. PubMed ID: 10725703
[TBL] [Abstract][Full Text] [Related]
6. Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.
Kato K; Cantwell MJ; Sharma S; Kipps TJ
J Clin Invest; 1998 Mar; 101(5):1133-41. PubMed ID: 9486984
[TBL] [Abstract][Full Text] [Related]
7. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation.
Ford GS; Barnhart B; Shone S; Covey LR
J Immunol; 1999 Apr; 162(7):4037-44. PubMed ID: 10201926
[TBL] [Abstract][Full Text] [Related]
8. In vitro engagement of CD3 and CD28 corrects T cell defects in chronic lymphocytic leukemia.
Bonyhadi M; Frohlich M; Rasmussen A; Ferrand C; Grosmaire L; Robinet E; Leis J; Maziarz RT; Tiberghien P; Berenson RJ
J Immunol; 2005 Feb; 174(4):2366-75. PubMed ID: 15699173
[TBL] [Abstract][Full Text] [Related]
9. CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia.
Wierda WG; Cantwell MJ; Woods SJ; Rassenti LZ; Prussak CE; Kipps TJ
Blood; 2000 Nov; 96(9):2917-24. PubMed ID: 11049967
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of CD30+ T cells by leukemia impairs isotype switching in normal B cells.
Cerutti A; Kim EC; Shah S; Schattner EJ; Zan H; Schaffer A; Casali P
Nat Immunol; 2001 Feb; 2(2):150-6. PubMed ID: 11175813
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of T cell/B cell interaction by B-CLL cells.
Kneitz C; Goller M; Wilhelm M; Mehringer C; Wohlleben G; Schimpl A; Tony HP
Leukemia; 1999 Jan; 13(1):98-104. PubMed ID: 10049067
[TBL] [Abstract][Full Text] [Related]
12. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22.
Ghia P; Strola G; Granziero L; Geuna M; Guida G; Sallusto F; Ruffing N; Montagna L; Piccoli P; Chilosi M; Caligaris-Cappio F
Eur J Immunol; 2002 May; 32(5):1403-13. PubMed ID: 11981828
[TBL] [Abstract][Full Text] [Related]
13. Lenalidomide treatment promotes CD154 expression on CLL cells and enhances production of antibodies by normal B cells through a PI3-kinase-dependent pathway.
Lapalombella R; Andritsos L; Liu Q; May SE; Browning R; Pham LV; Blum KA; Blum W; Ramanunni A; Raymond CA; Smith LL; Lehman A; Mo X; Jarjoura D; Chen CS; Ford R; Rader C; Muthusamy N; Johnson AJ; Byrd JC
Blood; 2010 Apr; 115(13):2619-29. PubMed ID: 19965642
[TBL] [Abstract][Full Text] [Related]
14. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
[TBL] [Abstract][Full Text] [Related]
15. Role of CD40-dependent down-regulation of CD154 in impaired induction of CD154 in CD4(+) T cells from HIV-1-infected patients.
Subauste CS; Subauste A; Wessendarp M
J Immunol; 2007 Feb; 178(3):1645-53. PubMed ID: 17237414
[TBL] [Abstract][Full Text] [Related]
16. Induction of functional CD154 (CD40 ligand) in neonatal T cells by cAMP-elevating agents.
Suárez A; Mozo L; Gayo A; Simó A; Gutiérrez C
Immunology; 2000 Aug; 100(4):432-40. PubMed ID: 10929069
[TBL] [Abstract][Full Text] [Related]
17. Decreased CD154 expression by neonatal CD4+ T cells is due to limitations in both proximal and distal events of T cell activation.
Jullien P; Cron RQ; Dabbagh K; Cleary A; Chen L; Tran P; Stepick-Biek P; Lewis DB
Int Immunol; 2003 Dec; 15(12):1461-72. PubMed ID: 14645155
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.
Kater AP; Dicker F; Mangiola M; Welsh K; Houghten R; Ostresh J; Nefzi A; Reed JC; Pinilla C; Kipps TJ
Blood; 2005 Sep; 106(5):1742-8. PubMed ID: 15914559
[TBL] [Abstract][Full Text] [Related]
19. CD154 gene therapy for human B-cell malignancies.
Messmer D; Kipps TJ
Ann N Y Acad Sci; 2005 Dec; 1062():51-60. PubMed ID: 16461788
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of CD40 ligand in activated CD4+ T lymphocytes of systemic sclerosis patients.
Valentini G; Romano MF; Naclerio C; Bisogni R; Lamberti A; Turco MC; Venuta S
J Autoimmun; 2000 Aug; 15(1):61-6. PubMed ID: 10936029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
